Skip to main content

Month: May 2024

Safe & Green Holdings Reports Year-End 2023 Results

Reports 30% Increase in Construction Services Revenue Compared to 2022 Completed Successful Spin-Out of Safe and Green Development Corporation as a Nasdaq Listed Publicly Traded Company Cost-Saving Initiatives Expected to Save $2.5 Million in Annualized Expenses to be Recognized in 2024 Partnering with Tunnel to Towers Foundation to Construct Travelling Modular Home to Showcase Foundation’s Homeless Veteran Program MIAMI, May 08, 2024 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, reported results for the year ended December 31, 2023. Recent Highlights:Achieves 30% year-over-year increase in construction services revenue for the year ended December 31, 2023 Executed...

Continue reading

ATA Creativity Global Schedules 2024 First Quarter Financial Results Release and Conference Call

BEIJING, May 08, 2024 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced that it will release financial results for the first quarter ended March 31, 2024, after the close of the stock market on Tuesday, May 14, 2024. The Company will discuss those results in a conference call the following day, Wednesday, May 15, 2024, at 8:30 a.m. ET.Participant Dial-in NumbersU.S. & Canada (Toll-Free): +1 (877) 407-9122International (Toll): +1 (201) 493-6747     Local AccessChina: (400) 120 2840Hong Kong: (800) 965561   WebcastThe call will also be made available via online webcast. Investors may access...

Continue reading

Dyadic to Attend Industry and Investor Events in May

JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that its management will be attending the following industry and investor events during the month of May 2024. PEGS BostonOmni Boston Hotel at The Seaport, Boston, MAMay 13 – 17, 2024 EFHutton Annual Global ConferenceThe Plaza Hotel, New York CityMay 15, 2024 ECI Vaccine Technology IXSecrets Puerto Los Cabos Resort Hotel, San José del Cabo, B.C.S., MexicoMay 19 – 24, 2024Novel Expression Track: “Development...

Continue reading

REMINDER/Supremex Announces Date of Its 2024 First Quarter Results Conference Call and Annual Meeting of Shareholders

MONTREAL, May 08, 2024 (GLOBE NEWSWIRE) — Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, will release its results for the first quarter ended March 31, 2024, after markets close Wednesday, May 8, 2024. A conference call to discuss these results will be held on Thursday, May 9, 2024, at 8:30 a.m. (Eastern Time). Conference Call: A live broadcast of the Conference Call will be available on the Company’s website, in the Investors section under Webcast. To participate (professional investment community only) or to listen to the live conference call, please dial the following numbers. We suggest that participants call-in at least 5 minutes prior to the scheduled start time:  • Confirmation number: 10023227  •...

Continue reading

PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com

TEL AVIV, Israel, May 08, 2024 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform, participated in an interview with Proactiveinvestors.com. During the interview, Mr. Hadar discussed the advantages of PRF-110 to help tackle the opioid epidemic, including its ability to provide extended post-operative pain relief without the use of opioids, as well as the market potential for the product, and positive updates on the Company’s ongoing Phase 3 clinical trial. The interview can be viewed on Proactiveinvestors.com or on their YouTube channel:https://www.youtube.com/@Proactive247 About Proactive InvestorsProactive...

Continue reading

Sow Good to Hold First Quarter 2024 Conference Call on Wednesday, May 15, 2024 at 10:00 a.m. ET

IRVING, Texas, May 08, 2024 (GLOBE NEWSWIRE) — Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, will hold a conference call on Wednesday, May 15, 2024 at 10:00 a.m. Eastern time to discuss its results for the first quarter ended March 31, 2024. The Company will provide its financial results in a press release prior to the conference call. Date: Wednesday, May 15, 2024Time: 10:00 a.m. Eastern timeRegistration Link: https://register.vevent.com/register/BI7a0e5e0068cb4e8fbef9f1e4833c0930 To access the call by phone, please register via the registration link above and you will be provided with dial-in instructions and details. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860. The conference call will...

Continue reading

Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Doug Treco, Ph.D., CEO and Chairman of Inozyme, will participate in a fireside chat at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 from 6:40-7:10pm ET / 3:40-4:10pm PT. A live webcast of the fireside chat can be accessed from the Investor Relations section of Inozyme’s website under events, where a replay of the event will also be available for a limited time. About Inozyme Pharma Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of...

Continue reading

Vital Farms’ Egg Central Station Earns Prestigious LEED® Gold Certification Recognizing Environmental Excellence in Manufacturing Standards

AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) — Vital Farms’ (Nasdaq: VITL) 2022 expansion of its egg washing and packing facility, Egg Central Station (ECS) in Springfield, MO, has been awarded LEED® Gold Certification for New Construction and Major Renovations. LEED® (Leadership in Energy and Environmental Design) is the U.S. Green Building Council’s (USGBC) internationally recognized green building rating system and a symbol of excellence in environmental stewardship. This prestigious acknowledgment underscores Vital Farms’ commitment to raising the standards in the food industry and progress made towards the company’s impact goal of reducing operational greenhouse gas intensity by 25% by 2027. “When we designed Egg Central Station and its expansion, we challenged ourselves to build a facility that fully embodies our purpose—to...

Continue reading

Vemanti’s VinHMS Secures Groundbreaking Partnership with Swiss-Belhotel International

IRVINE, Calif., May 08, 2024 (GLOBE NEWSWIRE) — Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTCQB: VMNT), a leading technology holding company, today announced a groundbreaking partnership between its wholly-owned subsidiary, VinHMS Pte. Ltd. (“VinHMS”) and Swiss-Belhotel International (“Swiss-Belhotel”), an international hospitality management group. Under a 3-year agreement, VinHMS will lead the implementation of state-of-the-art digital infrastructure for the prestigious Epic Tower Swiss-Belresidences in Hanoi, Vietnam. Leveraging VinHMS’s flagship product, CiHMS, this strategic alliance aims to enhance guest experiences, optimize operations, and elevate the overall efficiency of the brand new 5-star residence and office complex project. This landmark collaboration marks another pivotal moment for VinHMS and reinforces...

Continue reading

Perma-Fix Environmental Services Commends EPA on Regulatory and Enforcement Measures for PFAS

Highlights advantages of its new PFAS destruction technology as a preferred alternative to landfills, deep well injection and incineration ATLANTA, May 08, 2024 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today applauded the U.S. Environmental Protection Agency (EPA) for setting strict new regulatory and enforcement measures related to per- and polyfluoroalkyl substances (PFAS). The new regulatory measures include:Designation of PFAS as hazardous substances, which enables the agency to compel responsible parties to pay for or conduct investigations and cleanup, as well as the addition of seven additional PFAS to the list of chemicals covered by the Toxics Release Inventory (TRI). Issuing a Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) enforcement discretion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.